SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-20-006349
Filing Date
2020-04-14
Accepted
2020-04-14 15:01:39
Documents
49
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 573900
2 ex31-1.htm EX-31.1 11565
3 ex31-2.htm EX-31.2 11603
4 ex32-1.htm EX-32.1 6169
5 ex32-2.htm EX-32.2 5594
  Complete submission text file 0001493152-20-006349.txt   2932604

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE capd-20191231.xml EX-101.INS 364157
7 XBRL SCHEMA FILE capd-20191231.xsd EX-101.SCH 31654
8 XBRL CALCULATION FILE capd-20191231_cal.xml EX-101.CAL 36164
9 XBRL DEFINITION FILE capd-20191231_def.xml EX-101.DEF 111758
10 XBRL LABEL FILE capd-20191231_lab.xml EX-101.LAB 215018
11 XBRL PRESENTATION FILE capd-20191231_pre.xml EX-101.PRE 173839
Mailing Address 20 RAOUL WALLENBERG ST., TEL AVIV, L3 6971916
Business Address 20 RAOUL WALLENBERG ST., TEL AVIV, L3 6971916 972-3-6130421
CANNAPOWDER, INC. (Filer) CIK: 0001086082 (see all company filings)

IRS No.: 870626333 | State of Incorp.: UT | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26027 | Film No.: 20791128
SIC: 2834 Pharmaceutical Preparations